Journal of Clinical Endocrinology and Metabolism

Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States.  108:706-712. 2023

Pharmacologic Weight Management in the Era of Adolescent Obesity.  107:2716-2728. 2022

Changes in Type 2 Diabetes Trends in Children and Adolescents During the COVID-19 Pandemic.  107:E2777-E2782. 2022

C-reactive Protein and Racial Differences in Type 2 Diabetes Incidence: The REGARDS Study.  107:E2523-E2531. 2022

Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India.  107:E2267-E2275. 2022

PCOS and Mendelian Randomization: Too Soon?.  107:E2195-E2196. 2022

New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications..  107:e1339-e1347. 2022

Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.  107:E912-E923. 2022

Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.  107:575-585. 2022

Insulin Resistance and Cardiometabolic Risk Profile among Nondiabetic American Young Adults: Insights from NHANES.  107:E25-E37. 2022

Case Studies in Pediatric Lipid Disorders and Their Management.  106:3605-3620. 2021

Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients without Diabetes.  106:E4360-E4371. 2021

Proinsulin to C-Peptide Ratio in the First Year after Diagnosis of Type 1 Diabetes.  106:E4318-E4326. 2021

Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.  106:E3483-E3494. 2021

The Association of Lactation Duration with Visceral and Pericardial Fat Volumes in Parous Women: The CARDIA Study.  106:1821-1831. 2021

Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS.  106:E2151-E2161. 2021

Long-term change in physiological markers and cognitive performance in type 2 diabetes: The look ahead study.  105. 2020

Race, ancestry, and Vitamin D metabolism: The multi-ethnic study of atherosclerosis.  105. 2020

Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction.  105. 2020

Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study..  105:e3400-e3414. 2020

Letter to the Editor: "Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations".  105. 2020

Adipocyte insulin resistance in PCOS: Relationship with GLUT-4 expression and whole-body glucose disposal and β-cell function.  105. 2020

Biomarkers and noncalcified coronary artery plaque progression in older men treated with testosterone.  105. 2020

Prostate-Specific Antigen Levels during Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial.  104:6238-6246. 2019

Improving Long-Term Outcomes of Youth with Lipid Abnormalities - Expanding the Role of Pediatric Endocrinologists.  104:4421-4426. 2019

JC viruria is associated with reduced risk of diabetic kidney disease.  104:2286-2294. 2019

Female Pattern Hair Loss and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee.  104:2875-2891. 2019

The effect of testosterone on cardiovascular biomarkers in the testosterone trials.  103:681-688. 2018

ACTIVExtend: 24 Months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis.  103:2949-2957. 2018

Letter to the Editor: “Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis”.  102:3865-3866. 2017

The relationship between the score on a simple measure of cognitive function and incident CVD in people with diabetes: A post hoc epidemiological analysis from the accord-mind study.  102:3218-3225. 2017

No increase in fractures after stopping hormone therapy: Results from the women's health initiative.  102:302-308. 2017

Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded?.  102:4421-4427. 2017

Triglyceride levels and fracture risk in midlife women: Study of women's health across the nation (SWAN).  101:3297-3305. 2016

Testosterone treatment and sexual function in older men with low testosterone levels.  101:3096-3104. 2016

Erratum: Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and B cell function in overweight adults (J Clin Endocrinol (2013) 98:7 (E1173-E1180) doi: 10.1210/jc.2013-1203).  101:2265. 2016

Vitamin D supplementation modulates t cell-mediated immunity in humans: Results from a randomized control trial.  101:533-538. 2016

Bone mineral density as a predictor of subsequent wrist fractures: Findings from the women's health initiative study.  100:4315-4324. 2015

Impact of phosphorus-based food additives on bone and mineral metabolism.  100:4264-4271. 2015

Development of a weighted cardiometabolic disease staging (CMDS) system for the prediction of future diabetes.  100:3871-3877. 2015

Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.  100:1146-1155. 2015

Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et al.  100. 2015

Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individuals.  100:E182-E186. 2015

The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome.  99:E2754-E2761. 2014

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).  99:817-826. 2014

Insulin resistance indices are inversely associated with vitamin D binding protein concentrations.  99:178-183. 2014

Polycystic ovary syndrome: What's in a name?.  99:1142-1145. 2014

α-Internexin: A novel biomarker for pancreatic neuroendocrine tumor aggressiveness.  99. 2014

The severity of menstrual dysfunction as a predictor of insulin resistance in pcos.  98. 2013

Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.  98. 2013

Hypercortisolism is associated with increased coronary arterial atherosclerosis: Analysis of noninvasive coronary angiography using multidetector computerized tomography.  98:2045-2052. 2013

Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.  98:1541-1548. 2013

Update on treatment strategies for obesity.  98:1299-1306. 2013

20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.  98. 2013

Associations of Total and Undercarboxylated Osteocalcin with Peripheral and Hepatic Insulin Sensitivity and β-Cell Function in Overweight Adults.  98. 2013

Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.  97:4004-4013. 2012

Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility.  97. 2012

Skeletal muscle lipid peroxidation and insulin resistance in humans.  97. 2012

Association of intact parathyroid hormone levels with subsequent hip BMD loss: The Osteoporotic Fractures in Men (MrOS) study.  97:1937-1944. 2012

Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.  97. 2012

Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: Implications for progesterone actions in human pregnancy and parturition.  97. 2012

Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: The CARDIA study.  97:1337-1346. 2012

Adolescent diet and metabolic syndrome in young women: Results of the Dietary Intervention Study in Children (DISC) follow-up study.  96. 2011

Smad2: A candidate gene for the murine autoimmune diabetes locus Idd21.1.  96. 2011

Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjögren's syndrome.  96:3302-3307. 2011

Cardiac natriuretic peptides, obesity, and insulin resistance: Evidence from two community-based studies.  96:3242-3249. 2011

Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with β-cell function.  96. 2011

Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism..  96:E1142-E1147. 2011

Adiposity, inflammation, and risk for death in black and white men and women in the United States: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  96:1805-1814. 2011

Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome.  96. 2011

Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome.  96. 2011

Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered β-cell function.  96. 2011

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology & Metabolism (2010) 95 (4133-4160)).  95:5137. 2010

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline.  95:4133-4160. 2010

DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).  95:4985-4992. 2010

Postmenopausal hormone therapy: An endocrine society scientific statement.  95:s1-s66. 2010

Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: The "coronary artery risk development in young adults" women's study.  95:4424-4431. 2010

Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: Role of tumor necrosis factor-α.  95:935-942. 2010

Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.  95:4625-4634. 2010

The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: A report from the los angeles atherosclerosis study.  95:4432-4440. 2010

Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.  94:3282-3288. 2009

Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using ⁴¹Ca methodology.  94:3798-3805. 2009

Effect of dietary adherence with or without exercise on weight loss: A mechanistic approach to a global problem.  94:1602-1607. 2009

Homocysteine levels and risk of hip Fracture in postmenopausal women.  94:1207-1213. 2009

Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.  94:17-20. 2009

Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17β-hydroxysteroid dehydrogenase gene.  94:5034-5038. 2009

Loss of rap1GAP in papillary thyroid cancer.  94:1026-1032. 2009

Neuropsychological features in primary hyperparathyroidism: A prospective study.  94:1951-1958. 2009

Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.  94:1097-1103. 2009

Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men.  94:2773-2780. 2009

Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents.  94:3200-3206. 2009

Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: Comparative efficacy of ergocalciferol, cholecalciferol, and UV light.  94:2037-2043. 2009

Vitamin D deficiency in older men.  94:1214-1222. 2009

Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.  93:2909-2912. 2008

Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.  93:1939-1945. 2008

Associations among insulin, estrogen, and fat mass gain over the pubertal transition in African-American and european-american girls.  93:2610-2615. 2008

Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women.  93:1796-1803. 2008

Changes over 14 years in androgenicity and body mass index in a biracial cohort of reproductive-age women.  93:2158-2165. 2008

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.  93:3785-3793. 2008

Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.  93:809-814. 2008

Impact of obesity on the risk for polycystic ovary syndrome.  93:162-168. 2008

Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents.  93:4917-4923. 2008

Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.  93:300-303. 2008

Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects (Journal of Clinical Endocrinology and Metabolism 92, (1814-1820)).  93:1082. 2008

Polycystic ovary syndrome is a family affair.  93:1579-1581. 2008

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation.  93:1276-1284. 2008

Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.  93:4268-4275. 2008

Relationship of fat distribution with adipokines in human immunodeficiency virus infection.  93:216-224. 2008

Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies.  93:1062-1071. 2008

Thyroid hormones directly alter human hair follicle functions: Anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation.  93:4381-4388. 2008

Analysis of the Fc receptor-like-3 (FCRL3) locus in caucasians with autoimmune disorders suggests a complex pattern of disease association.  92:1106-1111. 2007

Brief report: The age-associated decline of androgens in reproductive age and menopausal black and white women.  92:4730-4733. 2007

Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation.  92:1909-1919. 2007

Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.  92:2659-2664. 2007

Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects.  92:1814-1820. 2007

Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement.  92:405-413. 2007

Soy isoflavones do not affect bone resorption in postmenopausal women: A dose-response study using a novel approach with⁴¹Ca.  92:577-582. 2007

Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.  91:2631-2637. 2006

Phytoestrogens and lipoproteins in women.  91:2209-2213. 2006

A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.  91:1526-1534. 2006

Degree of facial and body terminal hair growth in unselected black and white women: Toward a populational definition of hirsutism.  91:1345-1350. 2006

Editorial: Uncoupling protein 3 and human metabolism.  91:1226-1228. 2006

Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature.  91:781-785. 2006

Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline.  91:4237-4245. 2006

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.  91:48-53. 2006

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.  91:3451-3456. 2006

Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.  91:4085-4091. 2006

Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study.  90:6072-6076. 2005

Erratum: Effects of Aging on Cytochrome B5 Expression in the Human Adrenal Gland (The Journal of Clinical Endocrinology and Metabolism (2005) 90 (4357-4361)).  90:5286. 2005

Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes.  90:4920-4923. 2005

Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span.  90:4650-4658. 2005

Resistin stimulation of 17α-hydroxylase activity in ovarian theca cells in Vitro: Relevance to polycystic ovary syndrome.  90:4852-4857. 2005

Effects of aging on cytochrome B5 expression in the human adrenal gland.  90:4357-4361. 2005

Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.  90:4350-4356. 2005

Voluntary weight reduction in older men increases hip bone loss: The osteoporotic fractures in men study.  90:1998-2004. 2005

Association of the intestinal fatty acid-binding protein Ala ⁵⁴Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women.  90:1196-1201. 2005

Autosomal dominant resistance to thyrotropin as a distinct entity in five multigenerational kindreds: Clinical characterization and exclusion of candidate loci.  90:4025-4034. 2005

Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.  90:66-71. 2005

Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.  89:5558-5562. 2004

Diet, insulin resistance, and obesity: Zoning in on data for Atkins dieters living in South Beach.  89:4197-4205. 2004

The prevalence and features of the polycystic ovary syndrome in an unselected population.  89:2745-2749. 2004

Hormones & you: patient information page. Hormones and obesity..  89. 2004

Androgen Excess in Women: Experience with over 1000 Consecutive Patients.  89:453-462. 2004

Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone.  88:5137-5144. 2003

Relationship between serum leptin concentration and low-density muscle in postmenopausal women.  88:1157-1161. 2003

Influence of family history of type 2 diabetes on insulin sensitivity in prepubertal children.  88:192-195. 2003

Editorial: Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling.  87:4085-4087. 2002

Contribution of insulin secretion and clearance to glucose-induced insulin concentration in african-american and caucasian children..  87:2218-2224. 2002

Contribution of insulin secretion and clearance to glucose-induced insulin concentration in African-American and Caucasian children.  87:2218-2224. 2002

Troglitazone use in polycystic ovary syndrome [4].  86:5090-5091. 2001

Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking..  86:5450-5456. 2001

Longitudinal changes in body fat in African American and Caucasian children: Influence of fasting insulin and insulin sensitivity.  86:3182-3187. 2001

Adrenocortical secretion of dehydroepiandrosterone in healthy women: Highly variable response to adrenocorticotropin.  86:2513-2517. 2001

Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin..  86:2513-2517. 2001

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial.  86:1626-1632. 2001

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial..  86:1626-1632. 2001

Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: Implications regarding defects in vesicle trafficking.  86:5450-5456. 2001

Weight loss is not associated hyperleptinemia in humans pancreatic cancer.  86:162-166. 2001

Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women.  85:4476-4480. 2000

Comment on extrapituitary parasellar macroadenoma in cushing's disease [1].  85:2082. 2000

Effects of aging on adrenal function in the human: Responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.  85:48-54. 2000

Leptin in postmenopausal women: Influence of hormone therapy, insulin, and fat distribution.  85:1770-1775. 2000

The skin produces urocortin.  85:815-823. 2000

Comment on extrapituitary parasellar macroadenoma in Cushing's disease..  85:2082. 2000

Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution..  85:1770-1775. 2000

Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin.  85:3582-3588. 2000

Impact of architectural disruption on adrenocortical steroidogenesis in vitro..  84:1017-1021. 1999

Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level..  84:946-950. 1999

Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans.  84:3579-3585. 1999

Hypertension in women.  84:1862-1866. 1999

Impact of architectural disruption on adrenocortical steroidogenesis in vitro.  84:1017-1021. 1999

Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.  84:946-950. 1999

Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.  83:2317-2323. 1998

Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study.  83:3078-3082. 1998

Characterization of corticotropin-releasing hormone (CRH) in human skin.  83:1020-1024. 1998

Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).  83:1976-1987. 1998

The effect of 17β-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women.  83:519-524. 1998

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study..  83:3078-3082. 1998

Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis..  83:2317-2323. 1998

Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)..  83:1976-1987. 1998

Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.  83:3219-3224. 1998

Serum leptin and energy expenditure in children..  82:4149-4153. 1997

Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children.  82:2148-2152. 1997

Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children..  82:2148-2152. 1997

The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.  82:1293-1300. 1997

The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure..  82:1293-1300. 1997

Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.  82:479-485. 1997

Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate.  82:465-472. 1997

Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism..  82:479-485. 1997

Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate..  82:465-472. 1997

Aging alters zonation in the adrenal cortex of men.  82:3898-3901. 1997

Serum leptin and energy expenditure in children.  82:4149-4153. 1997

Role of the β3-adrenergic receptor locus in obesity and noninsulin- dependent diabetes among members of Caucasian families with a diabetic sibling pair.  81:4422-4427. 1996

ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin.  81:2746-2749. 1996

ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin..  81:2746-2749. 1996

Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles..  80:2437-2446. 1995

Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells..  80:1027-1031. 1995

Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.  80:400-405. 1995

Erratum: Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells (Journal of Clinical Endocrinology and Metabolism (1995) 80 (1027-1031)).  80:1971. 1995

Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children.  80:172-178. 1995

Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells.  80:1027-1031. 1995

Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: A prospective randomized study.  80:3406-3411. 1995

Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: Effects on blood flow and differential expression of GLUT 4 in skeletal muscles.  80:2437-2446. 1995

Clinical review 56: nonclassic adrenal hyperplasia: Current concepts.  78:810-815. 1994

Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues.  78:234-236. 1994

Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women.  79:1747-1751. 1994

Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles..  77:286-289. 1993

Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles.  77:286-289. 1993

Adrenocorticotropin interferes with transforming growth factor-β-induced growth inhibition of neocortical cells from the human fetal adrenal gland.  75:1519-1521. 1992

Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation.  73:1327-1331. 1991

The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women.  72:1025-1030. 1991

Acute adrenocorticotropin-(1–24) (ACTH) adrenal stimulation in eumenorrheic women: Reproducibility and effect of acth dose, subject weight, and sampling time.  70:1273-1279. 1990

Changes in Endocrine Function after Adrenal Medullary Transplantation to the Central Nervous System.  71:773-776. 1990

On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.  70:431-436. 1990

21-Hydroxylase Deficiency in Female Hyperandrogenism: Screening and Diagnosis.  69:577-584. 1989

CV 205–502 treatment of hyperprolactinemia.  68:336-339. 1989

Methionine-enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary.  66:804-810. 1988

The effects of dexamethasone and anencephaly on newborn serum levels of apolipoprotein A-1..  65:1098-1101. 1987

In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-Deficient individuals.  64:98-105. 1987

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study.  60:698-705. 1985

Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.  60:559-568. 1985

Thyrotropin (TSH)-induced hyperthyroidism: Response of TSH to dopamine and its agonists.  58:255-261. 1984

Umbilical Cord Plasma Levels of Dehydroepiandrosterone Sulfate during Human Gestation.  54:1216-1220. 1982

Diurnal patterns and regulation of cortisol secretion in pregnancy.  51:466-472. 1980

Plasma angiotensin converting enzyme activity in mother and fetus.  46:434-439. 1978

Effects of ph and enzyme inhibitors on apparent generation of angiotensin i in human plasma.  39:965-968. 1974